Characterized by chronic widespread pain, fibromyalgia presents complex problems in both its diagnosis and treatment. Fibromyalgia is a fairly common condition, affecting 2-4% of the population. The condition's prevalence has increased dramatically since 1990. The condition is not new, but has been known by various names, such as fibrositis and myofascial pain syndrome until 1990, when the American College of Rheumatology (ACR) published new classification criteria and first used the name fibromyalgia. The absence of objective diagnostic testing and the overlap with other condition often leads to a significant delay in diagnosis. There is a general misconception that the condition is unresponsive to treatment. However, published research shows that diagnosing and managing fibromyalgia leads to meaningful improvement in the patient's symptons and quality of life. Patients with fibromyalgia often demonstrate symptons additional to pain and are consquently diagnosed with one or more co-occurring syndromes and conditions, complicating diagnosis and treatment. The comorbidities most commonly associated wtih fibromyalgia are sleep disturbance, depression, anxiety, and other psychiatric disorders. Another condition frequently demonstrated by fibromylgia patients is irritable bowel syndrome. Chronic fatigue syndrome also commonly co-occurs, and is often confused wtih fibromyalgia upon initial diagnosis. Numerous pharmacological therapy options exist to treat pain and related symptons of fibromyalgia. Achievement of desired treatment outcomes requires careful patient selection, drug administration and monitoring. Accurate diagnosis of chronic pain syndromes is critical, as some commonly used medications to treat many pain conditions are relatively ineffective wtih fibromyalgia. Despite increasing recognition as a relatively common cause of chronic pain, fibromyalgia continues to generate controversy among clinicians. Given the intricate and challenging nature of treating fibromyalgia and comorbid disorders, it is imperative to educate primary care providers on the initial symptons, complications, and treatment strategies for fibromyalgia, as most patients with the condition will see a primary care provider for initial diagnosis/referral, and follow-up-care. In the years since the release of the ACR criteria, increasing recognition and advances in research have provided key insights into the etiology of fibromyalgia, resulting in the use of several successful pharmacological, as well as non-pharmacological, treatment approaches. However, despite the efforts of professional medical organizations and patient care groups, awareness of the current state of clinical assessment and treatment of fibromyalgia by healthcare professionals continues to be lacking. This book is designed to provide a succint and practical guide to help primary care physicians, internists, specialists, and allied health professionals effectively diagnose and manage patients with fibromyalgia. This concise volume will provide an essential understanding of the pathophysiology of the pain, subtypes, and pitfalls in the diagnosis of this chronic condition.
Characterized by chronic widespread pain, fibromyalgia presents complex problems in both its diagnosis and treatment. Fibromyalgia is a fairly common condition, affecting 2-4% of the population. The condition's prevalence has increased dramatically since 1990. The condition is not new, but has been known by various names, such as fibrositis and myofascial pain syndrome until 1990, when the American College of Rheumatology (ACR) published new classification criteria and first used the name fibromyalgia. The absence of objective diagnostic testing and the overlap with other condition often leads to a significant delay in diagnosis. There is a general misconception that the condition is unresponsive to treatment. However, published research shows that diagnosing and managing fibromyalgia leads to meaningful improvement in the patient's symptons and quality of life. Patients with fibromyalgia often demonstrate symptons additional to pain and are consquently diagnosed with one or more co-occurring syndromes and conditions, complicating diagnosis and treatment. The comorbidities most commonly associated wtih fibromyalgia are sleep disturbance, depression, anxiety, and other psychiatric disorders. Another condition frequently demonstrated by fibromylgia patients is irritable bowel syndrome. Chronic fatigue syndrome also commonly co-occurs, and is often confused wtih fibromyalgia upon initial diagnosis. Numerous pharmacological therapy options exist to treat pain and related symptons of fibromyalgia. Achievement of desired treatment outcomes requires careful patient selection, drug administration and monitoring. Accurate diagnosis of chronic pain syndromes is critical, as some commonly used medications to treat many pain conditions are relatively ineffective wtih fibromyalgia. Despite increasing recognition as a relatively common cause of chronic pain, fibromyalgia continues to generate controversy among clinicians. Given the intricate and challenging nature of treating fibromyalgia and comorbid disorders, it is imperative to educate primary care providers on the initial symptons, complications, and treatment strategies for fibromyalgia, as most patients with the condition will see a primary care provider for initial diagnosis/referral, and follow-up-care. In the years since the release of the ACR criteria, increasing recognition and advances in research have provided key insights into the etiology of fibromyalgia, resulting in the use of several successful pharmacological, as well as non-pharmacological, treatment approaches. However, despite the efforts of professional medical organizations and patient care groups, awareness of the current state of clinical assessment and treatment of fibromyalgia by healthcare professionals continues to be lacking. This book is designed to provide a succint and practical guide to help primary care physicians, internists, specialists, and allied health professionals effectively diagnose and manage patients with fibromyalgia. This concise volume will provide an essential understanding of the pathophysiology of the pain, subtypes, and pitfalls in the diagnosis of this chronic condition.
Fibromyalgia is a form of chronic neuromuscular pain, a pain-amplification syndrome brought on by abnormal interactions between hormones, the immune system, neurotransmitters, and the autonomic nervous system, that afflicts six million Americans every year. Often misdiagnosed, and widely misunderstood, the majority of patients are turned away from doctors or treated for depression. This guide offers expert advice to sufferers of this painful syndrome and gives them the education they need to get the help they require but rarely get. In their earlier books, Making Sense of Fibromyalgia and All About Fibromyalgia, noted medical writer Janice Wallace and Dr. Daniel Wallace, a leading expert on this disorder, provided comprehensive guides--for both patients and professionals--to this little known and poorly understood syndrome. Now, in Fibromyalgia, the Wallaces provide an inviting and succinct version of the syndrome they have studied, laid out in clear and accessible language. The authors provide a clear, concise explanation of the syndrome and its symptoms, and also outline the recent advances in treatments. Fibromyalgia addresses a desperate need for concise, accessible information on this syndrome and offers reassurance to patients and their families.
The latest edition of Making Sense of Fibromyalgia is written by well known, widely published experts in the field. It distills complex concepts of amplified pain into a easily readable and understandable narrative. This monograph is aimed at college educated laypersons, allied health professionals, patients, and treating physicians.
This year, six million Americans--most of them women--will go to their doctors, complaining of an illness they have no name for. The majority will be turned away or treated for depression; the few who persist will go to an average of four doctors before they receive the correct diagnosis: fibromyalgia. In their earlier Making Sense of Fibromyalgia, noted medical writer Janice Wallace and Dr. Daniel Wallace, a leading expert on this disorder, provided a comprehensive guide--for both patients and professionals--to this little known and poorly understood syndrome. Now, in All About Fibromyalgia, the Wallaces provide a thoroughly revised and updated version of that highly successful volume, incorporating a wealth of new information. This edition provides the current understanding of the disease as well as the latest drug treatments--all laid out in clear and accessible language. As in the previous volume, the authors provide a detailed, yet clear explanation of the disease. Fibromyalgia, they explain, is a form of chronic neuromuscular pain, a pain-amplification syndrome brought on by abnormal interactions between hormones, the immune system, neurotransmitters, and the autonomic nervous system. Sometimes the syndrome occurs spontaneously; in most cases, the authors write, it is associated with trauma, stress, such conditions as lupus and hypothyroidism, and over forty microbes, from hepatitis to Epstein-Barr to Lyme disease. Drawing on actual cases to illustrate their points, the authors help break through the isolation that patients often feel when doctors misdiagnose or simply ignore their symptoms. All About Fibromyalgia addresses a desperate need for information on this disease and offers reassurance to patients and their families.
In this book, public health ethicist Daniel S. Goldberg sets out to characterize the subjective experience of pain and its undertreatment within the US medical establishment, and puts forward public policy recommendations for ameliorating the undertreatment of pain. The book begins from the position that the overwhelming focus on opioid analgesics as a means for improving the undertreatment of pain is flawed, and argues instead that dominant Western models of biomedicine and objectivity delegitimize subjective knowledge of the body and pain in the US. This general intolerance for the subjectivity of pain is part of a specific American culture of pain in which a variety of actors take part, including not only physicians and health care providers, but also pain sufferers, caregivers, and policymakers. Concentrating primarily on bioethics, history, and public policy, the book brings a truly interdisciplinary approach to an urgent practical ethical problem. Taking up the practical challenge, the book culminates in a series of policy recommendations that provide pathways for moral agents to move beyond contests over drug policy to policy arenas that, based on the evidence, hold more promise in their capacity to address the devastating and inequitable undertreatment of pain in the US.
Integrative Rheumatology offers a new and much-needed perspective in disease and symptom management, blending conventional medicine with alternative approaches not typically included in a Western medical practice. While conventional treatments can provide considerable symptomatic relief and can even slow the progression of many rheumatologic conditions, integrative treatment incorporating lifestyle interventions, mind-body approaches, and practices such as acupuncture and meditation into conventional medical therapies can improve quality of life, reduce medication dosages, and are generally better tolerated. In this book, researchers and clinicians highlight specific gaps in conventional rheumatologic care and examine how alternative approaches may be ideally suited to address these missed opportunities. Here, the authors introduce topics not typically addressed in conventional rheumatology texts, including nutritional therapies, exercise, herbal medicine, mind/body approaches, Ayurveda, and energy medicine. The contributors, all of whom have a background in academic medicine, share the approaches that they have found most effective in their own practices, basing their work on the best scientific evidence available. Ultimately, an understanding of complementary and alternative approaches to healing can help clinicians care for their patients using the best proven therapies to modify disease progress and relieve pain and disability.
A state-by-state analysis of the expansion of medical marijuana access in the United States As of 2023, thirty-eight states and the District of Columbia have legalized the medical use of marijuana. Twenty-three have legalized recreational use, supporting what is now a flourishing multibillion-dollar industry. In Green Rush, Daniel J. Mallinson and A. Lee Hannah offer a fascinating history of cannabis legalization in America, highlighting the people, states, and policies that made these victories possible. With sharp insight, Mallinson and Hannah explore the backdrop to this sea change in policy, including shifts in public opinion, growing opposition to the War on Drugs, the promise of new revenue streams, and more. They examine the complex web of state actors—and the steps they took—to chart a path forward for marijuana legalization, from grassroots activists and interest groups to elected officials and other key policymakers. Mallinson and Hannah show us how states like Pennsylvania, Ohio, and West Virginia not only created, legitimized, and spread medical marijuana policy but also learned from each other’s successes and failures throughout the process. As marijuana legalization increasingly finds its way onto state ballots, Green Rush offers fresh insight into how we got here as a country and where we are going—one state at a time.
Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. Pain After Surgery offers an in-depth, comprehensive overview of basic and clinical research in the field. It presents the current knowledge and expertise of top global researchers on changes in central nervous system function accompanying and following surgery, as a model of chronic pain development. It also translates scientific understanding into effective clinical management of acute and persistent pain after surgery, including preoperative interventions to decrease the risk of chronification of postsurgical pain.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.